Rankings
▼
Calendar
PTCT (PTC Therapeutics, Inc.) Stock Financials & Earnings | Market Cap Arena
PTCT
PTC Therapeutics, Inc.
Mkt Cap
$6B
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$1.7B
Net Income (TTM)
$683M
EPS (TTM)
$7.74
Free Cash Flow (TTM)
$699M
Gross Margin
91.0%
Op. Margin
49.5%
Net Margin
39.4%
FCF Margin
40.4%
P/S Ratio (TTM)
3.4x
P/E Ratio (TTM)
8.6x
YoY Rev Growth
+114.5%
Employees
—
Earnings Reports
▶
Q4 2025
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$220M
$206M
-$118M
Q2 23
$214M
$201M
-$210M
Q3 23
$197M
$187M
-$118M
Q4 23
$307M
$201M
$3M
Q1 24
$210M
$195M
-$45M
Q2 24
$187M
$171M
-$40M
Q3 24
$197M
$186M
-$55M
Q4 24
$213M
$197M
-$162M
Q1 25
$1.2B
$1.2B
$970M
Q2 25
$179M
$167M
-$35M
Q3 25
$211M
$95M
$3M
Q4 25
$165M
$148M
-$82M
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
7.6x
—
Q2 23
7.1x
—
Q3 23
7.3x
—
Q4 23
6.2x
—
Q1 24
6.3x
—
Q2 24
6.5x
—
Q3 24
6.5x
—
Q4 24
7.2x
—
Q1 25
3.3x
9.8x
Q2 25
3.3x
9.3x
Q3 25
3.3x
7.8x
Q4 25
3.4x
8.6x
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
-$29M
-$73M
Q2 23
-$14M
-$33M
Q3 23
-$15M
-$44M
Q4 23
-$100M
-$129M
Q1 24
$71M
$6M
Q2 24
-$71M
-$64M
Q3 24
-$77M
-$88M
Q4 24
-$30M
-$37M
Q1 25
$870M
$868M
Q2 25
-$58M
-$62M
Q3 25
-$66M
-$70M
Q4 25
-$34M
-$37M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$44M
Q2 23
$19M
Q3 23
$29M
Q4 23
$28M
Q1 24
$64M
Q2 24
$7M
Q3 24
$11M
Q4 24
$6M
Q1 25
$3M
Q2 25
$4M
Q3 25
$3M
Q4 25
$2M
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
+48.2%
+43.7%
Q2 23
+29.2%
+64.2%
Q3 23
-9.5%
+8.3%
Q4 23
+83.4%
-17.4%
Q1 24
-4.7%
-24.4%
Q2 24
-12.7%
-46.4%
Q3 24
+0.1%
-20.2%
Q4 24
-30.6%
+23.6%
Q1 25
+459.7%
-19.4%
Q2 25
-4.2%
-5.8%
Q3 25
+7.2%
-17.2%
Q4 25
-22.7%
-34.4%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$29M
13.1%
Q2 23
$59M
27.6%
Q3 23
$27M
13.7%
Q4 23
$17M
5.4%
Q1 24
$18M
8.7%
Q2 24
$19M
10.3%
Q3 24
$20M
10.0%
Q4 24
$17M
8.1%
Q1 25
$18M
1.5%
Q2 25
$19M
10.4%
Q3 25
$19M
9.2%
Q4 25
$0
0.0%
marketcaparena.com
OpEx Breakdown
R&D
G&A
SG&A
Quarter
R&D
G&A
SG&A
Q1 23
$195M
—
$87M
Q2 23
$186M
—
$88M
Q3 23
$164M
$81M
—
Q4 23
$121M
$81M
—
Q1 24
$116M
—
$73M
Q2 24
$132M
—
$70M
Q3 24
$161M
—
$73M
Q4 24
$125M
—
$85M
Q1 25
$109M
—
$81M
Q2 25
$113M
—
$85M
Q3 25
$100M
—
$84M
Q4 25
$133M
—
$100M
marketcaparena.com
Revenue Segments
Manufacturing
Product
Royalty
Collaboration and License Revenue
Quarter
Manufacturing
Product
Royalty
Collaboration and License Revenue
Q2 24
$800K
$133M
$53M
—
Q3 24
$800K
$135M
$61M
—
Q1 25
—
$153M
$36M
$986M
Q2 25
—
$118M
$58M
$3M
Q3 25
—
$131M
$71M
$9M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$167M
$119M
$286M
Q2 23
$208M
$130M
$338M
Q3 23
$165M
$130M
$295M
Q4 23
$594M
$283M
$877M
Q1 24
$548M
$336M
$885M
Q2 24
$655M
$439M
$1.1B
Q3 24
$526M
$487M
$1.0B
Q4 24
$780M
$360M
$1.1B
Q1 25
$1.5B
$547M
$2.0B
Q2 25
$1.0B
$972M
$2.0B
Q3 25
$673M
$1.0B
$1.7B
Q4 25
$985M
$961M
$1.9B
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
74M
+1.5%
Q2 23
75M
+1.4%
Q3 23
75M
+0.9%
Q4 23
76M
+0.2%
Q1 24
76M
+1.3%
Q2 24
77M
+0.3%
Q3 24
77M
+0.3%
Q4 24
77M
+0.4%
Q1 25
86M
+11.9%
Q2 25
78M
-9.5%
Q3 25
87M
+11.5%
Q4 25
81M
-7.4%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 14
$119K
193
FY 15
$115K
320
FY 16
$272K
304
FY 17
$521K
373
FY 18
$512K
517
FY 19
$403K
761
FY 20
$394K
967
FY 21
$458K
1K
FY 22
$496K
1K
FY 23
$943K
995
FY 24
$807K
1K
FY 25
$30K
58K
marketcaparena.com